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Protein-protein interactions (PPIs) are broadly recognized
as an emerging target class for a whole new era in drug
discovery. They show significant differences to classical
target classes and have been regarded as “undruggable” for
a long time. Priaxon AG has developed a unique, proprie-
tary technology platform for PPI drug discovery. PriaX-
plore® employs novel computational and synthetic
approaches to address PPIs with small molecule modula-
tors. PriaXplore® utilizes Multicomponent Reactions
(MCRs) to create an in silico search space of 200 million
compounds pre-selected for PPI relevance. The PriaX-
plore® in silico screening process combines independent
descriptor systems to search the MCR product space with
maximum speed and accuracy. This combination of inde-
pendent description methods enables a highly efficient
selection of potential hit compounds that are further filter
by our in-house docking protocol PriaDock. As protein-
protein interaction sites are known to be very flexible and
binding pockets of small molecule modulators may not be
(fully) accessible in all protein structures, PriaDock uses
multiple protein conformations derived from crystal/NMR
structures or molecular dynamics simulations to account
for this flexibility. Thus, smaller sets of compounds have
to be synthesized and tested, lab resources are saved.
PriaXplore® has been validated by a successfully out-
licensed Mdm2/p53 PPI inhibitor program. Currently
PriaXplore® is applied in several drug discovery projects
which are run either as Priaxon in-house projects or as
cooperations with Pharma partners.
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